✦ LIBER ✦

New Immune Globulin Subcutaneous (Human), 10% (IGSC) Product is Well Tolerated in Subjects with Primary Immunodeficiency Diseases (PIDD)

✍ Scribed by Grossman, W.J.; Wasserman, R.L.; Melamed, I.; Stein, M.; Engl, W.; Leibl, H.; Schiff, R.I.; Gelmont, D.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy Analysis of Immune Globulin Sub

✍ Schiff, R.I.; Wasserman, R.L.; Melamed, I.; Stein, M.; Engl, W.; Leibl, H.; Gelm 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 42 KB

Pharmacokinetic Analysis (PK) of Immune

✍ Leibl, H.; Wasserman, R.L.; Melamed, I.; Stein, M.; Engl, W.; Schiff, R.I.; Gelm 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 44 KB

Octagam®5%, an Intravenous IgG Product,

✍ Hans D. Ochs; Paul J. Pinciaro; The Octagam Study Group 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 46 KB

Tolerability and Efficacy of Facilitated

✍ Wasserman, R.L.; Melamed, I.; Stein, M.; Puck, J.; Gupta, S.; Engl, W.; Leibl, H 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 41 KB

Pharmacokinetics (PK) of Human Immunoglo

✍ Stein, M.; Wasserman, R.L.; Melamed, I.; Puck, J.; Gupta, S.; Engl, W.; Leibl, H 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 39 KB

Pharmacokinetics and safety of subcutane

✍ R. L. Wasserman; A.-M. Irani; J. Tracy; C. Tsoukas; D. Stark; R. Levy; J. Chen; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 294 KB